Skip to main content

Taiko Pharmaceutical Co.,Ltd. (4574.T)

Japan Exchange Group Healthcare Drug Manufacturers - Specialty & GenericView data quality →
53.2Fair

ValueMarkers Composite Index

Top 43%#25,378 of 44,707

DCF data not available

Piotroski
7/9
Strong
Beneish
-2.48
Low Risk
Altman
4.01
Safe
DCF Value
-
N/A
ROIC
4.2%
Low
P/E
15.9
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Taiko Pharmaceutical Co.,Ltd. (4574.T) — VMCI valuation read

4574.T prints VMCI 53/100 inside the Healthcare sector, where the median sits at 50. The 3-point above-median delta is the cleanest single-number summary of Taiko Pharmaceutical Co.,Ltd.'s composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.

On 4574.T, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** 4574.T trades at 24.0x earnings, 33% above the Healthcare median of 18.0x; that is the value line. ROIC of 18.0% sits 8.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 3.1x is the binding constraint on the bear case; that is the risk line for Taiko Pharmaceutical Co.,Ltd. on the trailing financials.

4574.T rose 1.2% over the trailing 7 days, with a -9.2% read on a 30-day basis.

Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`

CEO: Takashi Shibata214 employeesJPwww.seirogan.co.jp

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 4574.T’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.